Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Shulman

Showing results (21-30 of 77) with videos related to

Pageof 8
Sort By:
Neurology|August 3, 1999
Transderm-induced psychosis in Parkinson's diseaseA Minagar, L M Shulman, W J Weiner
Neurology|March 1, 1996
Improvement of both tardive dystonia and akathisia after botulinum toxin injectionL M Shulman, C Singer, W J Weiner
Cytokine|January 1, 1992
Enhancement of interleukin 6 cytostatic effect on human breast carcinoma cells by soluble IL-6 receptor from urine and reversion by monoclonal antibodyD Novick, L M Shulman, L Chen, et al.
Advances in Neurology|July 20, 1999
Do we need more drugs to treat Parkinson's disease?W J Weiner, L M Shulman, W H Oertel
Bone Marrow Transplantation|October 19, 2001
CMV reactivation induced BK virus-associated late onset hemorrhagic cystitis after peripheral blood stem cell transplantationB Bielorai, L M Shulman, G Rechavi, et al.
Journal of Clinical Microbiology|May 1, 1995
Distribution of both rotavirus VP4 genotypes and VP7 serotypes among hospitalized and nonhospitalized Israeli childrenI Silberstein, L M Shulman, E Mendelson, et al.
Neurology|May 22, 1998
Acquired abducens-trigeminal synkinesisL M Shulman, B V Gallo, W J Weiner
Neurology|September 1, 1995
Psychosis as the initial manifestation of adult-onset Niemann-Pick disease type CL M Shulman, N J David, W J Weiner
Neurology|November 24, 1999
Amantadine-induced peripheral neuropathyL M Shulman, A Minagar, K Sharma, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 6, 2000
The use of dopamine agonists in very elderly patients with Parkinson's diseaseL M Shulman, A Minagar, A Rabinstein, et al.
Pageof 8

Showing results (21-30 of 77) with videos related to

Sort By:
Pageof 8
Neurology|August 3, 1999
Transderm-induced psychosis in Parkinson's diseaseA Minagar, L M Shulman, W J Weiner
Neurology|March 1, 1996
Improvement of both tardive dystonia and akathisia after botulinum toxin injectionL M Shulman, C Singer, W J Weiner
Cytokine|January 1, 1992
Enhancement of interleukin 6 cytostatic effect on human breast carcinoma cells by soluble IL-6 receptor from urine and reversion by monoclonal antibodyD Novick, L M Shulman, L Chen, et al.
Advances in Neurology|July 20, 1999
Do we need more drugs to treat Parkinson's disease?W J Weiner, L M Shulman, W H Oertel
Bone Marrow Transplantation|October 19, 2001
CMV reactivation induced BK virus-associated late onset hemorrhagic cystitis after peripheral blood stem cell transplantationB Bielorai, L M Shulman, G Rechavi, et al.
Journal of Clinical Microbiology|May 1, 1995
Distribution of both rotavirus VP4 genotypes and VP7 serotypes among hospitalized and nonhospitalized Israeli childrenI Silberstein, L M Shulman, E Mendelson, et al.
Neurology|May 22, 1998
Acquired abducens-trigeminal synkinesisL M Shulman, B V Gallo, W J Weiner
Neurology|September 1, 1995
Psychosis as the initial manifestation of adult-onset Niemann-Pick disease type CL M Shulman, N J David, W J Weiner
Neurology|November 24, 1999
Amantadine-induced peripheral neuropathyL M Shulman, A Minagar, K Sharma, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 6, 2000
The use of dopamine agonists in very elderly patients with Parkinson's diseaseL M Shulman, A Minagar, A Rabinstein, et al.
Pageof 8